Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis.
Miriana d'AlessandroFrancesca BellisaiLaura BergantiniPaolo CameliRoberto D'AlessandroMaria Antonietta MazzeiFrancesco GentiliEdoardo ConticiniEnrico SelviBruno FredianiMarco Matucci-CerinicElena BargagliPublished in: European journal of clinical investigation (2021)
These results suggest that serial measurements of KL-6 in the follow-up of these patients may help to monitor disease progression. In real life, in SSc-ILD patients PPFE should be always evaluated at CT and when present should suggest a tight follow-up to monitor its evolution.